PFE logo

Pfizer (PFE) Operating profit

annual operating profit:

$14.94B+$11.58B(+344.72%)
December 1, 2024

Summary

  • As of today (April 22, 2025), PFE annual operating income is $14.94 billion, with the most recent change of +$11.58 billion (+344.72%) on December 1, 2024.
  • During the last 3 years, PFE annual operating profit has fallen by -$8.77 billion (-36.98%).
  • PFE annual operating profit is now -59.92% below its all-time high of $37.27 billion, reached on December 31, 2022.

Performance

PFE Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

quarterly operating profit:

$3.19B-$2.10B(-39.70%)
December 1, 2024

Summary

  • As of today (April 22, 2025), PFE quarterly operating income is $3.19 billion, with the most recent change of -$2.10 billion (-39.70%) on December 1, 2024.
  • Over the past year, PFE quarterly operating profit has stayed the same.
  • PFE quarterly operating profit is now -74.33% below its all-time high of $12.41 billion, reached on June 1, 2022.

Performance

PFE quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

TTM operating profit:

$14.94B+$5.89B(+65.18%)
December 1, 2024

Summary

  • As of today (April 22, 2025), PFE TTM operating income is $14.94 billion, with the most recent change of +$5.89 billion (+65.18%) on December 1, 2024.
  • Over the past year, PFE TTM operating profit has stayed the same.
  • PFE TTM operating profit is now -60.30% below its all-time high of $37.62 billion, reached on September 1, 2022.

Performance

PFE TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

PFE Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+344.7%0.0%0.0%
3 y3 years-37.0%0.0%0.0%
5 y5 years+104.3%0.0%0.0%

PFE Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-59.9%+344.7%-74.3%+208.1%-60.3%+1744.0%
5 y5-year-59.9%+344.7%-74.3%+208.1%-60.3%+1744.0%
alltimeall time-59.9%+1692.2%-74.3%+162.1%-60.3%+731.3%

Pfizer Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$14.94B(+344.7%)
$3.19B(-39.7%)
$14.94B(+65.2%)
Sep 2024
-
$5.28B(+133.5%)
$9.04B(+1016.3%)
Jun 2024
-
$2.26B(-46.2%)
$810.00M(-17.9%)
Mar 2024
-
$4.20B(-255.2%)
$987.00M(-70.6%)
Dec 2023
$3.36B(-91.0%)
-$2.71B(-8.1%)
$3.36B(-70.3%)
Sep 2023
-
-$2.95B(-220.8%)
$11.32B(-52.7%)
Jun 2023
-
$2.44B(-62.9%)
$23.93B(-29.4%)
Mar 2023
-
$6.57B(+25.2%)
$33.90B(-9.1%)
Dec 2022
$37.27B(+57.2%)
$5.25B(-45.7%)
$37.27B(-0.9%)
Sep 2022
-
$9.67B(-22.1%)
$37.62B(+5.9%)
Jun 2022
-
$12.41B(+24.7%)
$35.51B(+22.8%)
Mar 2022
-
$9.95B(+77.8%)
$28.92B(+22.0%)
Dec 2021
$23.70B(+168.5%)
$5.59B(-25.9%)
$23.70B(+24.9%)
Sep 2021
-
$7.55B(+29.7%)
$18.97B(+36.8%)
Jun 2021
-
$5.82B(+23.1%)
$13.87B(+32.4%)
Mar 2021
-
$4.73B(+446.8%)
$10.48B(+18.7%)
Dec 2020
$8.83B(+20.8%)
$865.00M(-64.7%)
$8.83B(+164.5%)
Sep 2020
-
$2.45B(+0.7%)
$3.34B(-20.7%)
Jun 2020
-
$2.43B(-21.1%)
$4.21B(-29.0%)
Mar 2020
-
$3.08B(-166.6%)
$5.93B(-18.9%)
Dec 2019
$7.31B(+8.6%)
-$4.63B(-239.2%)
$7.31B(+7.4%)
Sep 2019
-
$3.32B(-19.9%)
$6.80B(-7.2%)
Jun 2019
-
$4.15B(-6.9%)
$7.33B(+1.8%)
Mar 2019
-
$4.46B(-186.9%)
$7.20B(+7.0%)
Dec 2018
$6.73B(-52.2%)
-$5.13B(-233.3%)
$6.73B(-52.8%)
Sep 2018
-
$3.85B(-4.3%)
$14.25B(+0.5%)
Jun 2018
-
$4.02B(+0.7%)
$14.18B(+1.5%)
Mar 2018
-
$3.99B(+67.1%)
$13.97B(-0.7%)
Dec 2017
$14.07B(+2.6%)
$2.39B(-36.8%)
$14.07B(+0.4%)
Sep 2017
-
$3.78B(-0.9%)
$14.02B(+1.6%)
Jun 2017
-
$3.81B(-6.9%)
$13.79B(+0.1%)
Mar 2017
-
$4.09B(+75.5%)
$13.77B(+0.5%)
Dec 2016
$13.71B(+5.7%)
$2.33B(-34.3%)
$13.71B(+0.5%)
Sep 2016
-
$3.55B(-6.4%)
$13.64B(-2.8%)
Jun 2016
-
$3.79B(-5.9%)
$14.03B(+0.8%)
Mar 2016
-
$4.03B(+78.3%)
$13.91B(+7.2%)
Dec 2015
$12.98B(-3.9%)
$2.26B(-42.6%)
$12.98B(-0.1%)
Sep 2015
-
$3.94B(+7.0%)
$12.99B(+2.2%)
Jun 2015
-
$3.68B(+18.9%)
$12.72B(-2.7%)
Mar 2015
-
$3.10B(+36.0%)
$13.07B(-3.2%)
Dec 2014
$13.50B(-17.5%)
$2.28B(-37.8%)
$13.50B(-9.4%)
Sep 2014
-
$3.66B(-9.1%)
$14.90B(-3.6%)
Jun 2014
-
$4.03B(+14.3%)
$15.45B(-2.8%)
Mar 2014
-
$3.53B(-4.1%)
$15.89B(-2.9%)
Dec 2013
$16.37B(-4.1%)
$3.68B(-12.8%)
$16.37B(+0.7%)
Sep 2013
-
$4.22B(-5.7%)
$16.25B(+1.0%)
Jun 2013
-
$4.47B(+11.7%)
$16.09B(-3.5%)
Mar 2013
-
$4.00B(+12.4%)
$16.67B(-4.0%)
Dec 2012
$17.07B(+1.6%)
$3.56B(-12.2%)
$17.36B(+7.2%)
Sep 2012
-
$4.05B(-19.7%)
$16.20B(-6.5%)
Jun 2012
-
$5.05B(+7.7%)
$17.32B(+3.3%)
Mar 2012
-
$4.69B(+95.5%)
$16.77B(-0.9%)
Dec 2011
$16.81B(+1.5%)
$2.40B(-53.7%)
$16.91B(-12.7%)
Sep 2011
-
$5.18B(+15.1%)
$19.38B(+17.9%)
Jun 2011
-
$4.50B(-7.0%)
$16.44B(-3.6%)
Mar 2011
-
$4.84B(-0.5%)
$17.06B(+3.0%)
Dec 2010
$16.56B(+5.3%)
$4.86B(+117.1%)
$16.56B(+8.8%)
Sep 2010
-
$2.24B(-56.2%)
$15.21B(-12.2%)
Jun 2010
-
$5.12B(+17.9%)
$17.34B(+9.7%)
Mar 2010
-
$4.34B(+23.2%)
$15.80B(-0.1%)
Dec 2009
$15.72B(+35.5%)
$3.52B(-19.3%)
$15.82B(+22.4%)
Sep 2009
-
$4.36B(+21.8%)
$12.93B(+4.4%)
Jun 2009
-
$3.58B(-17.8%)
$12.39B(+3.2%)
Mar 2009
-
$4.36B(+594.9%)
$12.00B(+4.9%)
Dec 2008
$11.60B(+12.2%)
$627.00M(-83.6%)
$11.44B(-14.6%)
Sep 2008
-
$3.82B(+19.7%)
$13.39B(+28.8%)
Jun 2008
-
$3.19B(-16.0%)
$10.40B(+10.7%)
Mar 2008
-
$3.80B(+47.5%)
$9.39B(-9.2%)
Dec 2007
$10.34B(-27.6%)
$2.58B(+210.0%)
$10.34B(-0.2%)
Sep 2007
-
$831.00M(-61.9%)
$10.36B(-22.7%)
Jun 2007
-
$2.18B(-54.0%)
$13.39B(-9.0%)
Mar 2007
-
$4.75B(+82.7%)
$14.71B(+3.0%)
Dec 2006
$14.28B(+0.5%)
$2.60B(-32.8%)
$14.28B(-5.4%)
Sep 2006
-
$3.87B(+10.3%)
$15.10B(+2.1%)
Jun 2006
-
$3.50B(-18.7%)
$14.78B(+1.8%)
Mar 2006
-
$4.31B(+26.4%)
$14.52B(+1.0%)
Dec 2005
$14.21B(-13.5%)
$3.41B(-4.0%)
$14.37B(-4.6%)
Sep 2005
-
$3.55B(+9.8%)
$15.06B(-5.5%)
Jun 2005
-
$3.24B(-22.3%)
$15.93B(-2.3%)
Mar 2005
-
$4.17B(+1.7%)
$16.31B(-0.7%)
Dec 2004
$16.43B
$4.10B(-7.3%)
$16.43B(+9.4%)
Sep 2004
-
$4.42B(+22.4%)
$15.01B(+13.9%)
DateAnnualQuarterlyTTM
Jun 2004
-
$3.62B(-15.7%)
$13.17B(+15.3%)
Mar 2004
-
$4.29B(+59.9%)
$11.42B(+7.5%)
Dec 2003
$10.37B(-15.2%)
$2.68B(+3.7%)
$10.63B(-8.0%)
Sep 2003
-
$2.59B(+38.6%)
$11.55B(-4.0%)
Jun 2003
-
$1.87B(-46.6%)
$12.03B(-4.8%)
Mar 2003
-
$3.49B(-3.0%)
$12.64B(+3.4%)
Dec 2002
$12.22B(+15.1%)
$3.60B(+17.5%)
$12.22B(+10.7%)
Sep 2002
-
$3.06B(+23.8%)
$11.04B(+2.1%)
Jun 2002
-
$2.48B(-19.5%)
$10.81B(-1.0%)
Mar 2002
-
$3.08B(+27.2%)
$10.92B(+2.7%)
Dec 2001
$10.61B(+23.9%)
$2.42B(-14.8%)
$10.63B(+0.6%)
Sep 2001
-
$2.84B(+9.8%)
$10.56B(+6.0%)
Jun 2001
-
$2.59B(-7.2%)
$9.96B(+7.7%)
Mar 2001
-
$2.79B(+18.5%)
$9.25B(+8.0%)
Dec 2000
$8.57B(+23.1%)
$2.35B(+5.1%)
$8.57B(+5.4%)
Sep 2000
-
$2.24B(+19.4%)
$8.13B(+8.9%)
Jun 2000
-
$1.87B(-11.0%)
$7.47B(+2.0%)
Mar 2000
-
$2.11B(+10.0%)
$7.32B(+14.9%)
Dec 1999
$6.96B(+30.1%)
$1.91B(+21.8%)
$6.37B(-9.0%)
Sep 1999
-
$1.57B(-9.0%)
$7.00B(+9.2%)
Jun 1999
-
$1.73B(+49.5%)
$6.41B(+14.6%)
Mar 1999
-
$1.16B(-54.6%)
$5.59B(+4.5%)
Dec 1998
$5.35B(+74.1%)
$2.54B(+158.8%)
$5.35B(+50.9%)
Sep 1998
-
$983.00M(+7.9%)
$3.54B(+4.6%)
Jun 1998
-
$911.00M(-0.2%)
$3.39B(+6.7%)
Mar 1998
-
$913.00M(+23.7%)
$3.17B(-0.5%)
Dec 1997
$3.07B(+12.0%)
$738.00M(-10.7%)
$3.19B(+9.4%)
Sep 1997
-
$826.00M(+18.5%)
$2.92B(-0.3%)
Jun 1997
-
$697.00M(-25.1%)
$2.93B(+4.4%)
Mar 1997
-
$930.00M(+100.4%)
$2.80B(+4.5%)
Dec 1996
$2.74B(+7.1%)
$464.00M(-44.4%)
$2.68B(-7.3%)
Sep 1996
-
$835.00M(+45.5%)
$2.89B(+5.2%)
Jun 1996
-
$574.00M(-29.0%)
$2.75B(+1.4%)
Mar 1996
-
$809.00M(+20.1%)
$2.71B(+7.0%)
Dec 1995
$2.56B(+29.8%)
$673.80M(-2.5%)
$2.53B(+7.2%)
Sep 1995
-
$691.40M(+28.9%)
$2.36B(+8.5%)
Jun 1995
-
$536.40M(-15.0%)
$2.18B(+6.8%)
Mar 1995
-
$630.90M(+25.5%)
$2.04B(+3.3%)
Dec 1994
$1.97B(+116.0%)
$502.90M(-0.8%)
$1.97B(+75.5%)
Sep 1994
-
$506.90M(+27.6%)
$1.12B(+5.5%)
Jun 1994
-
$397.20M(-29.8%)
$1.07B(-12.8%)
Mar 1994
-
$565.50M(-263.6%)
$1.22B(+6.8%)
Dec 1993
$913.30M(-36.7%)
-$345.60M(-177.1%)
$1.14B(-38.1%)
Sep 1993
-
$448.20M(-19.1%)
$1.85B(+2.5%)
Jun 1993
-
$553.70M(+13.5%)
$1.80B(+18.3%)
Mar 1993
-
$487.80M(+36.6%)
$1.52B(+5.5%)
Dec 1992
$1.44B(+15.1%)
$357.20M(-11.4%)
$1.44B(+7.2%)
Sep 1992
-
$403.00M(+46.9%)
$1.35B(+2.2%)
Jun 1992
-
$274.40M(-32.9%)
$1.32B(+2.2%)
Mar 1992
-
$408.80M(+56.7%)
$1.29B(+2.9%)
Dec 1991
$1.25B(+19.0%)
$260.80M(-30.2%)
$1.25B(+4.2%)
Sep 1991
-
$373.40M(+51.4%)
$1.20B(+3.9%)
Jun 1991
-
$246.60M(-33.8%)
$1.16B(+3.3%)
Mar 1991
-
$372.70M(+77.0%)
$1.12B(+6.4%)
Dec 1990
$1.05B(+8.8%)
$210.60M(-35.9%)
$1.05B(-144.5%)
Sep 1990
-
$328.50M(+57.0%)
-$2.37B(+88.4%)
Jun 1990
-
$209.30M(-31.5%)
-$1.26B(+672.0%)
Mar 1990
-
$305.40M(-109.5%)
-$162.70M(-116.8%)
Dec 1989
$968.20M(-4.3%)
-$3.21B(-323.1%)
$968.20M(-17.4%)
Sep 1989
-
$1.44B(+10.4%)
$1.17B(+5.0%)
Jun 1989
-
$1.30B(-9.3%)
$1.12B(-2.9%)
Mar 1989
-
$1.44B(-147.8%)
$1.15B(+13.7%)
Dec 1988
$1.01B(+7.6%)
-$3.01B(-317.3%)
$1.01B(-23.0%)
Sep 1988
-
$1.38B(+3.5%)
$1.31B(+6.9%)
Jun 1988
-
$1.34B(+3.0%)
$1.23B(+9.8%)
Mar 1988
-
$1.30B(-148.0%)
$1.12B(+19.0%)
Dec 1987
$940.80M(-2.0%)
-$2.70B(-308.3%)
$940.80M(-27.1%)
Sep 1987
-
$1.30B(+5.8%)
$1.29B(+11.7%)
Jun 1987
-
$1.23B(+9.6%)
$1.16B(+10.4%)
Mar 1987
-
$1.12B(-147.6%)
$1.05B(+9.1%)
Dec 1986
$959.70M(+9.1%)
-$2.35B(-302.3%)
$959.70M(-21.8%)
Sep 1986
-
$1.16B(+4.0%)
$1.23B(+14.0%)
Jun 1986
-
$1.12B(+8.3%)
$1.08B(+12.1%)
Mar 1986
-
$1.03B(-149.5%)
$960.20M(+9.9%)
Dec 1985
$880.00M(+5.6%)
-$2.09B(-306.0%)
$873.80M(-3.5%)
Sep 1985
-
$1.01B(+1.1%)
$905.70M(+3.4%)
Jun 1985
-
$1.00B(+5.9%)
$875.60M(+1.9%)
Mar 1985
-
$945.70M(-146.0%)
$859.40M(+3.1%)
Dec 1984
$833.50M
-$2.05B(-309.1%)
$833.50M(-71.1%)
Sep 1984
-
$982.70M(-0.3%)
$2.89B(+51.6%)
Jun 1984
-
$985.70M(+7.2%)
$1.91B(+107.2%)
Mar 1984
-
$919.80M
$919.80M

FAQ

  • What is Pfizer annual operating income?
  • What is the all time high annual operating profit for Pfizer?
  • What is Pfizer annual operating profit year-on-year change?
  • What is Pfizer quarterly operating income?
  • What is the all time high quarterly operating profit for Pfizer?
  • What is Pfizer quarterly operating profit year-on-year change?
  • What is Pfizer TTM operating income?
  • What is the all time high TTM operating profit for Pfizer?
  • What is Pfizer TTM operating profit year-on-year change?

What is Pfizer annual operating income?

The current annual operating profit of PFE is $14.94B

What is the all time high annual operating profit for Pfizer?

Pfizer all-time high annual operating income is $37.27B

What is Pfizer annual operating profit year-on-year change?

Over the past year, PFE annual operating income has changed by +$11.58B (+344.72%)

What is Pfizer quarterly operating income?

The current quarterly operating profit of PFE is $3.19B

What is the all time high quarterly operating profit for Pfizer?

Pfizer all-time high quarterly operating income is $12.41B

What is Pfizer quarterly operating profit year-on-year change?

Over the past year, PFE quarterly operating income has changed by $0.00 (0.00%)

What is Pfizer TTM operating income?

The current TTM operating profit of PFE is $14.94B

What is the all time high TTM operating profit for Pfizer?

Pfizer all-time high TTM operating income is $37.62B

What is Pfizer TTM operating profit year-on-year change?

Over the past year, PFE TTM operating income has changed by $0.00 (0.00%)
On this page